Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Shilpa Medicare Limited is recalling 4,166 bottles of Imatinib Mesylate 400 mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations.
Shilpa Medicare Limited is recalling 2,008 vials of Docetaxel Injection USP due to Current Good Manufacturing Practice (CGMP) deviations.
Asiaticon, SA de CV is recalling 111,500 units of Protz Antibacterial Hand Sanitizer distributed in Texas due to a lack of Current Good Manufacturing Practices (CGMPs).
MPM Medical LLC is recalling REGENECARE HA topical anesthetic hydrogel because it was found to be contaminated with Burkholderia cepacia bacteria.
Lohxa LLC is recalling Chlorhexidine Gluconate Oral Rinse USP, 0.12%, due to contamination with Burkholderia lata bacteria.
Torrent Pharma Inc. is recalling 2,496 bottles of Anagrelide Capsules, USP 1 mg, because the product failed to meet dissolution specifications.
Sunstar Americas is recalling Paroex Oral Rinse due to microbial contamination with Burkholderia lata. The recall covers specific lots distributed nationwide.
AA Products Inc. is recalling SYP Health Hand Sanitizer Alcohol Gel due to CGMP deviations and a history of subpotent ethanol and methanol contamination at the manufacturing facility.
Eywa Pharma Inc. is recalling 500 mg Levetiracetam tablets because a 1000 mg tablet was found in a 500 mg bottle.
Albek De Mexico is recalling Assured Instant Hand Sanitizer bottles because they contained methanol and had lower ethanol levels than labeled.
Ascent Pharmaceuticals is recalling 9,768 bottles of Hydrocodone Bitartrate and Acetaminophen Tablets because one bottle contained a Losartan Potassium tablet.
Albek De Mexico S.A. De C.V. is recalling Modesa Instant Hand Sanitizer because it contained methanol and had lower ethanol content than labeled.
Preferred Pharmaceuticals is recalling 99 bottles of Metformin HCl Extended Release Tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) levels exceeding the Acceptable Daily Intake Limit.
Albek De Mexico S.A. De C.V. is recalling Next Advanced Antibacterial Hand Sanitizer because it contained methanol and had lower ethanol levels than labeled.
Albek De Mexico S.A. De C.V. is recalling NuuxSan hand sanitizer because it contained methanol and had lower ethanol levels than labeled.
Albek De Mexico S.A. De C.V. is recalling 27,000 bottles of Assured Instant Hand Sanitizer because the product contained methanol and was below the label claim for ethanol content.
Baxter Healthcare is recalling specific lots of Bupivacaine Hydrochloride Injection due to the presence of black and transparent particles in the solution.
H & H Remedies, LLC is voluntarily recalling 365 bottles of White Liniment due to Current Good Manufacturing Practice (CGMP) deviations.
Denton Pharma, Inc. is recalling Metformin Hydrochloride Extended-Release Tablets 750 mg due to the detection of N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels.
PD-Rx Pharmaceuticals is recalling 125 bottles of Metformin Hydrochloride Extended Release tablets because of NDMA impurity levels above acceptable limits.
Denton Pharma, Inc. is recalling specific bottles of Metformin Hydrochloride Extended-Release Tablets 500 mg because they contain N-Nitrosodimethylamine (NDMA) above acceptable levels.
Nostrum Laboratories is recalling 20,872 bottles of Metformin Hydrochloride Extended-Release Tablets 500 mg because they contain N-Nitrosodimethylamine (NDMA) above acceptable levels.
PD-Rx Pharmaceuticals is recalling 1,683 bottles of Metformin Hydrochloride Extended Release 500 mg because of NDMA impurity levels above acceptable limits.
Direct Rx is recalling 88 bottles of Metformin Hydrochloride Extended Release 500 mg in Florida due to NDMA impurity levels above acceptable intake.
Time-Cap Labs, Inc. is recalling Metformin Hydrochloride Extended-Release Tablets 500 mg because the FDA detected the impurity N-Nitrosodimethylamine (NDMA) above acceptable intake levels.